APF welcomes new trustee Stephen Morgan-Hyland who lost his father to Idiopathic Pulmonary Fibrosis in 2017
Action for Pulmonary Fibrosis is delighted to welcome to the board of trustees, Stephen Morgan-Hyland.
Steve Jones, Chair of APF says:
We are delighted to welcome Stephen as a trustee of the charity. Stephen, like all trustees, has a direct connection to the disease. His high-level skills in strategic planning and management will be helpful in guiding the ambitious growth we plan for the charity over the next few years.
Stephen has over 20 years’ experience as a planning and property consultant and is a recognised expert in commercial development and regeneration. He is a Director at a leading planning and economics consultancy in Manchester, having previously been Commercial Planning Director at an internationally renowned property agency. He is involved with some of the largest commercial development projects in the UK.
Stephen lost his dad, Tony to Idiopathic Pulmonary Fibrosis in 2017. Tony had suffered with the condition for five years, but it was not picked up from the beginning and this meant that, by the time it was picked up, it was too late for any long term treatment.
Stephen is honoured to serve at a Trustee for Action for Pulmonary Fibrosis in his dad’s memory. He is driven to raise awareness of IPF in the interests of both ensuring that clinical advances continue to be achieved and that early diagnosis is made in as many cases as is possible.
He is a keen runner, and can often be seen in competitive races flying the Action for Pulmonary Fibrosis flag.
‘APF does such a magnificent job in raising awareness of IPF and providing support to those affected by the condition. When my dad died in 2017, it was a natural step for me to become involved with the charity in his memory, and contribute to the fantastic achievements to date. He died after having the illness for a number of years but was diagnosed too late for any long-term treatment. I intend to work with the other APF Trustees and supporters of APF in the interests of maximising the number of cases where early diagnosis is made.